Sigachi Industries has announced a board meeting to discuss the financial results for the quarter and half-year. The company secured approval for its new 25-acre Bulk Drugs and Specialty Chemicals facility in Andhra Pradesh, aiming to boost API manufacturing capacity and improve global supply chain efficiency. This expansion targets growth in regulated markets and stronger export potential, supporting Sigachi’s strategy to scale operations and enhance vertical integration in pharma ingredients.